Promoters hold 72.6% of Mankind Pharma Limited (MANKIND). FIIs hold 9.4%, mutual funds 10.9% and other DIIs 4.5%. No promoter pledge is reported. Quarterly shareholding, quarter ended Jun 26.
Folio counts aren't part of the shareholding pattern we ingest today — they arrive with a later filing parse.
| Holder | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 72.6% | 72.7% | 72.7% | 72.7% | 72.7% | 72.7% | 72.7% | 72.7% | 74.9% | 74.9% | 74.9% | 76.5% |
| FII | 9.4% | 10.2% | 11.3% | 12.8% | 13.1% | 12.9% | 13.3% | 13.3% | 12.4% | 11.6% | 9.9% | 6.7% |
| MF | 10.9% | 10.4% | 9.3% | 7.8% | 7.3% | 7.7% | 7.8% | 8.0% | 7.0% | 7.4% | 8.6% | 7.5% |
| Other DII | 4.5% | 4.1% | 4.0% | 4.1% | 4.2% | 3.8% | 3.2% | 3.0% | 2.9% | 2.6% | 2.6% | 2.2% |
| Retail & others | 2.5% | 2.6% | 2.8% | 2.6% | 2.8% | 2.9% | 2.9% | 2.9% | 2.9% | 3.6% | 4.1% | 7.0% |
No bulk or block deals disclosed for this stock in the last 90 days.
Bulk deals are uncommon for large caps — a single client has to trade over 0.5% of the company's shares in one day. Most weeks, none happen.
No PIT or SAST disclosures on record for this stock in the last 12 months.
That is the usual state — promoters, directors and holders above 5% file only when they trade or pledge; a new filing appears here within a day of reaching the exchange.
In Jun 26, FII holding fell −0.8pp and mutual funds +0.5pp, while retail trimmed −0.1pp. Falling institutional ownership can read as distribution — though institutions can be wrong, and it’s never a guarantee.
Quarterly shareholding patternas of Jun 26
